Chiralpedia

<๐“๐ก๐ž ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐‰๐จ๐ฎ๐ซ๐ง๐ž๐ฒ ๐จ๐Ÿ ๐‚๐ก๐ข๐ซ๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ> - Click to View
<The Regulatory Journey of Chiral Drugs> - Episode 1: When Mirror Images Mattered: A Historical Prelude to Chiral Drug Regulation
<The Regulatory Journey of Chiral Drugs> - Episode 2: The Great Shift: How the 1990s Redefined Stereochemical Standards
<The Regulatory Journey of Chiral Drugs> - Episode 3:Beyond Borders: Comparing How Global Agencies Regulate Chiral Drugs
<The Regulatory Journey of Chiral Drugs> - Episode 4: Technology as Catalyst: How Science Enabled the Regulatory Transformation
<The Regulatory Journey of Chiral Drugs> - Episode 5: Choosing the Right Twin: Regulatory Expectations for Single Enantiomers
<The Regulatory Journey of Chiral Drugs> - Episode 6: The Rise of the Chiral Switch: Strategy or Science?
<The Regulatory Journey of Chiral Drugs> - Episode 7: Clinical Questions: Are Single Enantiomers Always Better?
<The Regulatory Journey of Chiral Drugs> - Episode 8: Episode 8: Beyond the Approval: Ethical and Economic Dimensions of Chiral Drugs
<The Regulatory Journey of Chiral Drugs> - Episode 9: Challenges on the Horizon: Complex Chirality and Emerging Scientific Questions
<๐“๐ก๐ž ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐‰๐จ๐ฎ๐ซ๐ง๐ž๐ฒ ๐จ๐Ÿ ๐‚๐ก๐ข๐ซ๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ> - Click to View
<The Regulatory Journey of Chiral Drugs> - Episode 1: When Mirror Images Mattered: A Historical Prelude to Chiral Drug Regulation
<The Regulatory Journey of Chiral Drugs> - Episode 2: The Great Shift: How the 1990s Redefined Stereochemical Standards
<The Regulatory Journey of Chiral Drugs> - Episode 3:Beyond Borders: Comparing How Global Agencies Regulate Chiral Drugs
<The Regulatory Journey of Chiral Drugs> - Episode 4: Technology as Catalyst: How Science Enabled the Regulatory Transformation
<The Regulatory Journey of Chiral Drugs> - Episode 5: Choosing the Right Twin: Regulatory Expectations for Single Enantiomers
<The Regulatory Journey of Chiral Drugs> - Episode 6: The Rise of the Chiral Switch: Strategy or Science?
<The Regulatory Journey of Chiral Drugs> - Episode 7: Clinical Questions: Are Single Enantiomers Always Better?
<The Regulatory Journey of Chiral Drugs> - Episode 8: Episode 8: Beyond the Approval: Ethical and Economic Dimensions of Chiral Drugs
<The Regulatory Journey of Chiral Drugs> - Episode 9: Challenges on the Horizon: Complex Chirality and Emerging Scientific Questions

Chiral Biosensors

Chirality Meets Cutting-Edge Tech!

Chiral biosensors are changing the game in pharmaโ€”bringing speed, precision, and stereoselectivity to the forefront of drug development. When mirror-image molecules make all the difference, these sensors step up to ensure safety and efficacy in every dose.

Why It Matters:
  • Real-time enantiomer detectionโ€”boosting both speed and safety in drug pipelines
  • Next-gen techโ€”nanomaterials, aptamers & bio-interfaces delivering ultra-sensitive results
  • From lab to lifeโ€”applications in drug screening, personalized medicine & QC
  • Future-readyโ€”tackling miniaturization, AI-powered analysis & lab-on-a-chip integration

Read more @ the following article.

Chiral Biosensors: Precision Tools for Safer Drugs

Selvakumar Kanthiah & Valliappan Kannappan
Pharma Focus Europe, 05-06-2025

https://www.linkedin.com/posts/pharmafocuseurope_chiralbiosensors-pharmaceuticalinnovation-activity-7336349189141909505-c2jT/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAGX1w0BSRRIMrXG6HR1vlbAZYtlzWVE9Y4
https://www.pharmafocuseurope.com/articles/chiral-biosensors-precision-tools-for-safer-drugs
ยฉ 2025 Chiralpedia. All Rights Reserved. | Design by Krithi
Site Map Disclaimer